Rox Medical, Inc.
USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Rox ranks #17,141 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 3 technology areas.
- #17,141
- of 49,997 US assignees by volume
- 37th percentile
- by Innovation Score (31.1/100)
- 25.8
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17141 · US Corporation #17,141 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 17 grants
- MID-PACK #17,141/49,997
- PHOTO-FINISH Rose Acre Farms
- CPC-NARROW A61B · 3 areas
- INNOV-THIN 31.1/100
- CLAIMS-DENSE 25.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Rose Acre Farms, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Rox’s 31.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Rox
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Rox Medical · this assignee 31
Rox Medical · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Rox's Innovation Score is 31.1/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Rox?
Each dot is one of Rox’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rox’s own 25.8 claims/patent is ABOVE the 19.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Rox's grants concentrate
Rox Medical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (5 grants) versus a trough of 2 in 2016. By volume, Rox sits between Rose Acre Farms, Inc. and Safekey Engineering Technology (Zhengzhou), Ltd..
Who files at Rox's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Rose Acre Farms
Rose Acre Farms, Inc.
17 patents
- Rose Plastic
Rose Plastic AG
17 patents
- Ross Technology
Ross Technology LLC
17 patents
- Rovi Solutions
Rovi Solutions Corporation
17 patents
- Run Them Sweet
Run Them Sweet LLC
17 patents
- S M E Products
S.M.E. Products LP
17 patents
- Sacmi Imola S C
Sacmi Imola S.C.
17 patents
- Safekey Engineeri…
Safekey Engineering Technology (Zhengzhou), Ltd.
17 patents
- Rox Medical ◀
Rox Medical, Inc.
17 patents
What this shows Rox holds 17 patents at rank #17,139, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Rox
By rank, the assignees closest to #17,139 in granted patent volume.
- Rose Acre Farms, Inc. #17,135 · 17 patents
- Rose Plastic AG #17,136 · 17 patents
- Ross Technology LLC #17,137 · 17 patents
- Rovi Solutions Corporation #17,138 · 17 patents
- Run Them Sweet LLC #17,140 · 17 patents
- S.M.E. Products LP #17,141 · 17 patents
- Sacmi Imola S.C. #17,142 · 17 patents
- Safekey Engineering Technology (Zhengzhou), Ltd. #17,143 · 17 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Rox's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Rox's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 37th percentile higher than 37% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 29.4% |
| 2016 | 2 | 11.8% |
| 2017 | 5 | 29.4% |
| 2018 | 3 | 17.6% |
| 2019 | 2 | 11.8% |
Which technologies does Rox Medical, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Rox Medical, Inc.'s patent record in context - here's where to go next.
- Rox Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #17,141 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Rox Medical, Inc. against Rose Acre Farms, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.